Literature DB >> 9423662

Locally advanced rectal cancer: surgical complications after infusional chemotherapy and radiation therapy.

N A Janjan1, V S Khoo, T A Rich, P A Evetts, M S Goswitz, P K Allen, J M Skibber.   

Abstract

PURPOSE: To compare the surgical complication rate after further experience with infusional chemotherapy and radiation therapy for locally advanced rectal cancer.
MATERIALS AND METHODS: Preoperative radiation therapy (45 Gy in 25 fractions over 5 weeks) and concurrent continuous infusion of 5-fluorouracil (300 mg.m-2.d-1) were given to 117 patients with rectal cancer. Approximately 6 weeks after therapy, surgery was performed.
RESULTS: The histopathologic cancer stages were Tis-2N0 in 30 patients (26%), T2N1 in six (5%), T3N0 in 24 (21%), T3N1 in 18 (15%), T4N0 in six (5%), and T4N1 in one (1%); a complete response to preoperative therapy was histopathologically confirmed in 32 patients. A decrease in cancer stage allowed a sphincter-saving procedure in 68 patients (58%) and abdominoperineal resection in 49 patients (42%). Only one patient developed fistula; nine patients, perioperative wound complications; and four patients, pelvic infection. In the authors' previously reported chemotherapy and radiation therapy results (same protocol), eight (22%) of 37 patients developed fistulas and five (14%) developed pelvic abscess; in the authors' previous experience with preoperative radiation therapy only (median total dose, 45 Gy; dose range, 40.0-59.4 Gy), results were similar.
CONCLUSION: Surgical complications after chemotherapy and radiation therapy are statistically significantly (P < .05) reduced with further experience.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9423662     DOI: 10.1148/radiology.206.1.9423662

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  6 in total

Review 1.  Optimising treatment for resectable rectal cancer: is preoperative therapy beneficial?

Authors:  S Y Ngan
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

2.  Neoadjuvant radiation and chemotherapy in rectal cancer does not increase postoperative complications.

Authors:  G Valero; J A Luján; Q Hernández; M De Las Heras; E Pellicer; A Serrano; P Parrilla
Journal:  Int J Colorectal Dis       Date:  2003-07-15       Impact factor: 2.571

3.  Tumor response to neoadjuvant chemoradiation in rectal cancer: predictor for surgical morbidity?

Authors:  K Horisberger; R D Hofheinz; P Palma; A K Volkert; S Rothenhoefer; F Wenz; A Hochhaus; S Post; F Willeke
Journal:  Int J Colorectal Dis       Date:  2007-12-11       Impact factor: 2.571

4.  The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer.

Authors:  M J Murcia Duréndez; L Frutos Esteban; J Luján; M D Frutos; G Valero; J L Navarro Fernández; L Mohamed Salem; G Ruiz Merino; M A Claver Valderas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-19       Impact factor: 9.236

5.  CPT-11 and concomitant hyperfractionated accelerated radiotherapy induce efficient local control in rectal cancer patients: results from a phase II.

Authors:  V Voelter; A Zouhair; H Vuilleumier; M Matter; H Bouzourene; S Leyvraz; J Bauer; P Coucke; R Stupp
Journal:  Br J Cancer       Date:  2006-08-29       Impact factor: 7.640

6.  Assessment of clinical and pathological complete response after neoadjuvant chemoradiotherapy in rectal adenocarcinoma and its therapeutic implications.

Authors:  Sorin Tiberiu Alexandrescu; Adrian Vasile Dumitru; Ruxandra Doina Babiuc; Radu Virgil Costea
Journal:  Rom J Morphol Embryol       Date:  2021 Apr-Jun       Impact factor: 1.033

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.